Safety and Efficacy of Subcutaneous Cardioverter Defibrillator in Patients at High Risk of Sudden Cardiac Death ― Primary Japanese Experience ―

  • Sasaki Shingo
    Department of Advanced Management of Cardiac Arrhythmias, Hirosaki University Graduate School of Medicine
  • Tomita Hirofumi
    Department of Cardiology, Hirosaki University Graduate School of Medicine
  • Tsurugi Takuo
    Advanced Arrhythmia Therapeutic Branch, Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center
  • Ishida Yuji
    Department of Cardiology, Hirosaki University Graduate School of Medicine
  • Shoji Yoshihiro
    Department of Cardiology, Hirosaki University Graduate School of Medicine
  • Nishizaki Kimitaka
    Department of Cardiology, Hirosaki University Graduate School of Medicine
  • Kinjo Takahiko
    Department of Cardiology, Hirosaki University Graduate School of Medicine
  • Endo Tomohide
    Department of Cardiology, Hirosaki University Graduate School of Medicine
  • Nishizaki Fumie
    Department of Cardiology, Hirosaki University Graduate School of Medicine
  • Hanada Kenji
    Department of Cardiology, Hirosaki University Graduate School of Medicine
  • Sasaki Kenichi
    Department of Cardiology, Hirosaki University Graduate School of Medicine
  • Horiuchi Daisuke
    Department of Advanced Management of Cardiac Arrhythmias, Hirosaki University Graduate School of Medicine
  • Kimura Masaomi
    Department of Cardiology, Hirosaki University Graduate School of Medicine
  • Higuma Takumi
    Department of Cardiology, Hirosaki University Graduate School of Medicine
  • Okamatsu Hideharu
    Advanced Arrhythmia Therapeutic Branch, Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center
  • Tanaka Yasuaki
    Advanced Arrhythmia Therapeutic Branch, Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center
  • Koyama Junjiroh
    Advanced Arrhythmia Therapeutic Branch, Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center
  • Okumura Ken
    Advanced Arrhythmia Therapeutic Branch, Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center

この論文をさがす

抄録

<p>Background:The entirely subcutaneous implantable cardioverter defibrillator (S-ICD) was introduced as a new alternative to conventional transvenous ICD (TV-ICD) in Japan in February 2016, but its safety and efficacy are unclear.</p><p>Methods and Results:A total of 60 patients (48 men, median age, 60 years; IQR, 44–67 years; primary prevention, n=24) underwent S-ICD implantation between February 2016 and August 2017. The device pocket was formed in the intermuscular space between the serratus anterior muscle and the latissimus dorsi muscle, and the parasternal S-ICD lead was placed according to pre-implant screening. Defibrillation test was performed in 56 patients (93%). Ventricular fibrillation (VF) was induced in 55 patients and terminated by a single 65-J shock in all patients. The median time to shock therapy was 13.4 s (IQR, 12.1–14.9 s) and the median post-shock impedance of the S-ICD lead was 64 Ω (IQR, 58–77 Ω). There were no operation-related complications or subsequent infectious complications. During follow-up (median, 275 days; IQR, 107–421 days), 1 patient (1.7%) had appropriate shock for VF with successful termination, whereas 5 patients (8.3%) had inappropriate shock due to oversensing of myopotential (n=3) or T-wave (n=1), and detection of supraventricular tachycardia (n=1).</p><p>Conclusions:S-ICD is a safe and effective alternative to conventional TV-ICD. The long-term safety and efficacy of the S-ICD need further investigation.</p>

収録刊行物

  • Circulation Journal

    Circulation Journal 82 (6), 1546-1551, 2018-05-25

    一般社団法人 日本循環器学会

被引用文献 (2)*注記

もっと見る

参考文献 (15)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ